Novel Treatment Approaches in Recurrent/Metastatic Squamous Head and Neck Cancer.

01 February 2026

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.

31 December 2025

Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference.

31 December 2025

The accessory type III secretion system effectors collectively shape intestinal inflammatory infection outcomes.

31 December 2025

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.

31 December 2025

SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancer.

04 December 2025

Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms.

01 December 2025

Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study.

01 December 2025

Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis.

28 November 2025

Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase.

27 November 2025

The CIP2A-TOPBP1 axis facilitates mitotic DNA repair via MiDAS and MMEJ.

27 November 2025

Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union-a comparative overview.

26 November 2025